Antimicrobial stewardship in high-risk febrile neutropenia patients

被引:0
|
作者
Adrien Contejean
Salam Abbara
Ryme Chentouh
Sophie Alviset
Eric Grignano
Nabil Gastli
Anne Casetta
Lise Willems
Etienne Canouï
Caroline Charlier
Frédéric Pène
Julien Charpentier
Jeanne Reboul-Marty
Rui Batista
Didier Bouscary
Solen Kernéis
机构
[1] Université de Paris,Faculté de Médecine
[2] AP-HP,Service d’hématologie
[3] APHP.CUP,Équipe Mobile d’Infectiologie
[4] Hôpital Cochin,UVSQ, Inserm, CESP, Anti
[5] AP-HP,infective Evasion and Pharmacoepidemiology Team
[6] APHP.CUP,Laboratoire de bactériologie
[7] Hôpital Cochin,Institut Pasteur, Biology of Infection Unit, INSERM U1117
[8] Université Paris-Saclay,Service de médecine intensive réanimation
[9] Institut Pasteur,Département d’information médicale
[10] Epidemiology and Modelling of Antibiotic Evasion (EMAE),Pharmacie hospitalière
[11] AP-HP,INSERM, IAME
[12] APHP.CUP,undefined
[13] Hôpital Cochin,undefined
[14] Equipe opérationnelle d’hygiène hospitalière,undefined
[15] AP-HP,undefined
[16] Hôpital Cochin,undefined
[17] French National Reference Center and WHO Collaborating Center Listeria,undefined
[18] AP-HP,undefined
[19] APHP.CUP,undefined
[20] Hôpital Cochin,undefined
[21] AP-HP,undefined
[22] APHP.CUP,undefined
[23] Hôpital Cochin,undefined
[24] AP-HP,undefined
[25] APHP.CUP,undefined
[26] Hôpital Cochin,undefined
[27] Université de Paris,undefined
关键词
Antimicrobial stewardship; High-risk febrile neutropenia; Prognosis; Antibiotic consumption;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Comparison of cefepime and ceftazidime in combination with amikacin in the empirical treatment of high-risk patients with febrile neutropenia:: A prospective, randomized, multicenter study
    Erman, M
    Akova, M
    Akan, H
    Korten, V
    Ferhanoglu, B
    Köksal, I
    Çetinkaya, Y
    Uzun, Ö
    Ünal, S
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2001, 33 (11) : 827 - 831
  • [42] Importance of Risk Factors for Febrile Neutropenia Among Patients Receiving Chemotherapy Regimens Not Classified as High-Risk in Guidelines for Myeloid Growth Factor Use
    Weycker, Derek
    Li, Xiaoyan
    Barron, Rich
    Wu, Hongsheng
    Morrow, P. K.
    Xu, Hairong
    Reiner, Maureen
    Garcia, Jacob
    Mhatre, Shivani K.
    Lyman, Gary H.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (08): : 979 - +
  • [43] Risk of mortality in patients with cancer experiencing febrile neutropenia
    Barron, R.
    Michels, S. L.
    Reynolds, M. W.
    Tomic, K.
    Yu, J.
    Lyman, G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [44] Risk of mortality in patients with cancer experiencing febrile neutropenia
    Lyman, G. H.
    Michels, S. L.
    Tomic, K. E.
    Yu, J.
    Reynolds, M. W.
    Barron, R. L.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 176 - 177
  • [45] Risk Factors Predicting Outcome in Febrile Neutropenia Patients
    Aamir, S.
    Anwar, S.
    Faizan, M.
    Ahmad, A.
    [J]. PEDIATRIC BLOOD & CANCER, 2016, 63 : S98 - S98
  • [46] Risk Assessment of Adult Patients with Febrile Neutropenia and Malignancies
    Alejandria, Marissa M.
    Jamias, Jade
    Ecarma, Raquel
    Zoleta, Loreta
    Mendoza, Myrna
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 : S106 - S106
  • [47] Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia:: A multicenter randomized trial
    García-Carbonero, R
    Mayordomo, JI
    Tornamira, MV
    López-Brea, M
    Rueda, A
    Guillem, V
    Arcediano, A
    Yubero, A
    Ribera, F
    Gómez, C
    Trés, A
    Pérez-Gracia, JL
    Lumbreras, C
    Hornedo, J
    Cortés-Funes, H
    Paz-Ares, L
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (01) : 31 - 38
  • [48] Advances in antibacterial treatment of adults with high-risk febrile neutropenia (vol 78, pg 2109, 2023)
    Contejean, Adrien
    Maillard, Alexis
    Canoui, Etienne
    Kerneis, Solen
    Fantin, Bruno
    Bouscary, Didier
    Parize, Perrine
    Garcia-Vidal, Carolina
    Charlier, Caroline
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 (11) : 2784 - 2784
  • [49] Remote Monitoring of Patients With Hematologic Malignancies at High Risk of Febrile Neutropenia: Exploratory Study
    Kroloff, Maxwell
    Ramezani, Ramin
    Wilhalme, Holly
    Naeim, Arash
    [J]. JMIR FORMATIVE RESEARCH, 2022, 6 (01)
  • [50] Risk assessment and treatment of low-risk patients with febrile neutropenia
    Kern, WV
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 42 (04) : 533 - 540